326 related articles for article (PubMed ID: 26616639)
1. Peritoneal dialysate effluent and serum CA125 concentrations in stable peritoneal dialysis patients.
Redahan L; Davenport A
J Nephrol; 2016 Jun; 29(3):427-434. PubMed ID: 26616639
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic role of peritoneal CA 125 in peritoneal dialysis patients presenting with acute peritonitis.
Panorchan K; Davenport A
BMC Nephrol; 2014 Sep; 15():149. PubMed ID: 25217152
[TBL] [Abstract][Full Text] [Related]
3. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
4. Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis.
Krediet RT
Perit Dial Int; 2001; 21(6):560-7. PubMed ID: 11783764
[TBL] [Abstract][Full Text] [Related]
5. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis.
Do JY; Kim YL; Park JW; Chang KA; Lee SH; Ryu DH; Kim CD; Park SH; Yoon KW
Perit Dial Int; 2008 Jun; 28 Suppl 3():S101-6. PubMed ID: 18552237
[TBL] [Abstract][Full Text] [Related]
6. Expression of cancer antigen 125 by peritoneal mesothelial cells is not influenced by duration of peritoneal dialysis.
Sanusi AA; Zweers MM; Weening JJ; de Waart DR; Struijk DG; Krediet RT
Perit Dial Int; 2001; 21(5):495-500. PubMed ID: 11757834
[TBL] [Abstract][Full Text] [Related]
7. Dialysate CA125 levels in children on continuous peritoneal dialysis.
Turhan P; Sever L; Caliskan S; Kasapcopur O; Sever A; Hacibekiroglu M; Arisoy N
Pediatr Nephrol; 2005 Nov; 20(11):1615-21. PubMed ID: 16133054
[TBL] [Abstract][Full Text] [Related]
8. Effects of Icodextrin and Glucose Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids on Effluent Cell Population and Biocompatibility Markers IL-6 and CA125 in Incident Peritoneal Dialysis Patients.
Opatrná S; Pöpperlová A; Lysák D; Fuchsová R; Trefil L; Racek J; Topolčan O
Ther Apher Dial; 2016 Apr; 20(2):149-57. PubMed ID: 26929256
[TBL] [Abstract][Full Text] [Related]
9. Dialysate cell population and cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients: their relationship with transport parameters.
Lai KN; Lai KB; Szeto CC; Ho KK; Poon P; Lam CW; Leung JC
Am J Kidney Dis; 1997 May; 29(5):699-705. PubMed ID: 9159303
[TBL] [Abstract][Full Text] [Related]
10. Variability of effluent cancer antigen 125 and interleukin-6 determination in peritoneal dialysis patients.
Lopes Barreto D; Coester AM; Noordzij M; Smit W; Struijk DG; Rogers S; de Waart DR; Krediet RT
Nephrol Dial Transplant; 2011 Nov; 26(11):3739-44. PubMed ID: 21498425
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT
Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions.
Parikova A; Zweers MM; Struijk DG; Krediet RT
Adv Perit Dial; 2003; 19():186-90. PubMed ID: 14763059
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients.
Shioya M; Yoshida T; Kasai K; Furuya R; Kato A; Mori N; Matsumoto Y; Kumagai H
Nephrology (Carlton); 2013 Aug; 18(8):539-44. PubMed ID: 23718260
[TBL] [Abstract][Full Text] [Related]
14. The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis.
Akman S; van Westrhenen R; De Waart DR; Hiralall JK; Zweers MM; Krediet RT
Adv Perit Dial; 2003; 19():24-7. PubMed ID: 14763029
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group.
Posthuma N; ter Wee PM; Donker AJ; Oe PL; Peers EM; Verbrugh HA
Perit Dial Int; 2000; 20 Suppl 2():S106-13. PubMed ID: 10911654
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of changes in serum and dialysate levels of cancer antigen 125 in stable continuous ambulatory peritoneal dialysis patients.
Passadakis P; Panagoutsos S; Thodis E; Tsivara I; Sopassi F; Kartali S; Vargemezis V
Adv Perit Dial; 1999; 15():40-4. PubMed ID: 10682070
[TBL] [Abstract][Full Text] [Related]
17. Effect of icodextrin-based peritoneal dialysis solution on peritoneal membrane.
Moriishi M; Kawanishi H; Watanabe H; Tsuchiya S
Adv Perit Dial; 2005; 21():21-4. PubMed ID: 16686279
[TBL] [Abstract][Full Text] [Related]
18. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
[TBL] [Abstract][Full Text] [Related]
19. Short- and medium-term increase of CA125 in peritoneal effluent using a neutral-pH solution.
García H; Hernández-Jaras J; Cruz Mdel C; Agramunt I; Calvo C; Cerrillo V
Perit Dial Int; 2003; 23(4):375-80. PubMed ID: 12968846
[TBL] [Abstract][Full Text] [Related]
20. Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD.
Pannekeet MM; Zemel D; Koomen GC; Struijk DG; Krediet RT
Perit Dial Int; 1995; 15(6):217-25. PubMed ID: 7578497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
